The utility of exercise in this disease is uncertain.
A clinical trial is a test, in humans, of an experimental treatment. Although it's possible that benefit may be derived from participating in a clinical trial, it's also possible that no benefit, or even harm, may occur. MDA has no ability to influence who is chosen to participate in a clinical trial. To learn more, see Understanding Clinical Trials and Being a Co-Adventurer, which is about neuromuscular disease clinical trials. To see a continuously updated database of clinical trials, go to www.clinicaltrials.gov.
Those enrolled in the study will be randomly assigned to either a strength or a stretching exercise program.
The study requires two visits to the NIH in Bethesda, Md., 12 weeks of monitoring at home, and a four-week phone and email follow-up period. There are no associated costs to participants.
Those in the trial will be informed of the results and given an opportunity to learn any exercises that are found to be beneficial.
To participate in the SBMA exercise trial
Prospective participants must:
have genetically confirmed SBMA;
be willing and able to participate in a 12-week exercise regimen;
be able to walk short distances;
be able to participate in a 16-week study with two visits to the NIH in Bethesda, Md.; and